Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

The signing of the MoU reflects a shared commitment by UNAIDS and Africa CDC to drive progress towards the achievement of the Sustainable Development Goals, and the vision of a healthier, more ...

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

The rollout of antiretroviral therapy for HIV showed how global solidarity and smart policy can overcome barriers to new ...

Deputy Minister of Health, Dr Joe Phaahla, has hailed long-acting injectables such as Lenacapavir as a game-changer poised to revolutionise HIV prevention, especially for adolescent girls, young women ...

WASHINGTON (AP) — The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028, the State Department announced Thursday.

WASHINGTON, United States (AFP) — The United States will fund a program for affordable access to a groundbreaking HIV prevention drug in lower-income countries, the State Department said Thursday, ...

After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

CVS cites clinical, financial, and regulatory reasons for decision Yeztugo approved by FDA in June, nearly 100% effective in trials Medicare, VA, some Medicaid plans are already covering the drug CVS ...